紫錐菊 Echinacea

INT-echinacea-001 3 個適應症被研究
C 3

適應症與證據等級

法規與權威立場 (L4)

L4a · US FDA
立場:cautious
These products are unapproved new drugs sold in violation of section 505(a) of the Federal Food, Drug, and Cosmetic Act
來源 ↗
L4b · EU EFSA
立場:neutral
L4c · UK NHS
立場:neutral
Traditional herbal medicinal product used to relieve the symptoms of the common cold and influenza type infections, based on traditional use only.
來源 ↗
L4d · TW TFDA / 衛福部
立場:neutral
每日食用限量為九百毫克。二歲以下之幼童、糖尿病患者、患有免疫相關疾病者或正在使用免疫相關藥物治療者,在使用前須先諮詢醫療人員。
來源 ↗
L4e · WHO
立場:neutral
WHO Monographs on Selected Medicinal Plants includes monographs on Herba Echinaceae Purpureae and Radix Echinaceae, covering quality control and the traditional and clinical uses of these medicinal plant materials.
來源 ↗

市場與行銷 (L10)

L10a · TW Market Channels
紫錐花,防禦升級,機能保健,保健/醫療
L10b · TW Legal Identity (TFDA)
每日建議之食用限量為紫錐花萃取物 900 mg
L10c · TW Community (PTT/Dcard/Mobile01)
我們都覺得沒效,吃心安的